Results

Total Results: 1,886 records

Showing results for "tested".
Users also searched for: colon

161. FRN 27 - Wireless Motility Capsule Versus Other Diagnostic Technologies for Evaluating Gastroparesis and Constipation: Future Research Needs (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/wireless-motility-capsule-future_research.pdf
     May 01, 2013 - In an ideal world, all tested motility patients should have been weaned off all narcotics prior to any

162. Future Research Needs for Treatment of Obstructive Sleep Apnea (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/sleep-apnea-treatment-future_research.pdf
     February 01, 2012 - Population 5P: MAD tested primarily in a narrow population. … Design 6D: Studies commonly selectively reported analyses, in particular failing to report tested but … Population 5P: MAD tested primarily in a narrow population. … Design 6D: Studies commonly selectively reported analyses, in particular failing to report tested but … Interventions Treatment strategies should be tested both with and without the involvement of a sleep

163. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/antiplatelet-treatment_research-protocol.pdf
     November 22, 2011 - Evidence-based Practice Center Systematic Review Protocol Source: www.effectivehealthcare.ahrq.gov Published Online: November 22, 2011 1 Evidence-based Practice Center Systematic Review Protocol Project Title: Testing of CYP2C19 Variants and Platelet Reactivity for Guiding Antiplatelet Treatment I. …

164. For women, when comparing noninvasive testing,which testing method (echocardiography, MIBI-SPECT, pharmacological testing, etc.) is more accurate in diagnosing coronary artery disease. There has been inadequate studies done on women for… | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/get-involved/nominated-topics/for-women-when-comparing-noninvasive-testingwhich-testing-method-echocardiography-mibi-spect-pharmacological-testing-etc-is-more-accurate-in-diagnosing-coronary-artery-disease-there-has-been-inadequate-studies-done-on-women-

165. Breast-Biopsy-Update Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-biopsy-update_executive.pdf
     September 01, 2014 - We pilot-tested the forms on several studies extracted by multiple team members to ensure consistency

166. Appendicitis Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/appendicitis_executive.pdf
     December 01, 2015 - 1 Comparative Effectiveness Review Number 157 Diagnosis of Right Lower Quadrant Pain and Suspected Acute Appendicitis Executive Summary Background Abdominal pain is a common presenting symptom for patients seeking care at emergency departments, with approximately 3.4 million expected cases per year in the U…

167. Effective Health Care (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0334_08-04-2010.pdf
     January 01, 2010 - Effective Health Care Topic Number: 0285 Document Completion Date: 3-22-11 1 Results of Topic Selection Process & Next Steps  Pharmacogenetic testing for CYP2C19 variants for guiding antiplatelet treatment will go forward for refinement as a systematic review. The scope of this topic, including p…

168. PREGNANCY, INCLUDING PRETERM BIRTH #12 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/12_pregnancy_potential_high_impact_june_2012.pdf
     January 01, 2012 - Journal of Obstetrics and Gynecology. 51 In this study, 449 samples from a high-risk population were tested

169. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-abnormalities-tests_executive.pdf
     February 01, 2006 - Layout 1 Background Breast cancer is the second most common malignancy in women. The American Cancer Society estimated that in the United States in 2005, 212,930 women would be newly diagnosed as having breast cancer and there would be 40,870 deaths due to this disease. Because early breast cancer is asymptomatic, th…

170. Topic 0451 Celiac Disease NSD FINAL (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-533_05-24-2013.pdf
     January 01, 2013 - Topic 0451 Celiac Disease NSD FINAL …

171. PREGNANCY, INCLUDING PRETERM BIRTH #12 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pregnancy_hi_impact.pdf
     January 01, 2012 - Journal of Obstetrics and Gynecology. 47 In this study, 449 samples from a high-risk population were tested

172. Disposition of Comments Report for Noninvasive Technologies for the Diagnosis of Coronary Artery Disease in Women (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cad-women-diagnosis_disposition-comments.pdf
     June 12, 2012 - On ES-8 and on page 8, the authors state the aabstraction templates were "pilot tested to ensure consistency … Who pilot tested and how? Were the persons abstracting for the pilot the same as for this review? … need for an evaluation of diagnostic algorithms to ensure strategies for improving outcomes are tested

173. CER 174 Executive Summary: Imaging for the Pretreatment of Small Cell Lung Cancer (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/lung-cancer-staging_executive.pdf
     April 01, 2016 - • For quality of life (part of KQ2), this means reporting data on a previously tested quality-of-life

174. Ch 3-User-Guide-To-Ocer 130129 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/ch_3-user-guide-to-ocer_130129.pdf
     September 21, 2012 - Essentially, the study intent, design, and analysis are all focused on the subgroup hypotheses to be tested … Often, it is not clear how many hypotheses were tested (e.g., using stepwise model 40 Developing

175. Plasma-Cell-Dyscrasias-Sflc-Assay Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/plasma-cell-dyscrasias-sflc-assay_executive.pdf
     August 01, 2012 - 1 Comparative Effectiveness Review Number 73 Serum Free Light Chain Analysis for the Diagnosis, Management, and Prognosis of Plasma Cell Dyscrasias Executive Summary Background Plasma cell dyscrasias (PCDs) are a group of neoplastic disorders characterized by the uninhibited expansion of a monoclonal popula…

176. Diagnosis and Treatment of Clinical Alzheimer’s-Type Dementia: Evidence Summary (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/Evidence%20Summary_1.pdf
     April 01, 2020 - Diagnosis and Treatment of Clinical Alzheimer’s-Type Dementia: Evidence Summary Purpose of Review To summarize evidence on cognitive test accuracy for clinical Alzheimer’s-type dementia (CATD) in suspected cognitive impairment; biomarker accuracy for Alzheimer’s disease (AD) in dementia; and effects of CATD drug …

177. Hypertension-Pulmonary-Arterial Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/hypertension-pulmonary-arterial_executive.pdf
     April 01, 2013 - acute vasoreactivity testing response; however, acute vasoreactivity is seen in a minority of patients tested … We tested for heterogeneity using graphical displays and test statistics (Q and I2 statistics), while … of PAH • Echocardiographically guided and BNP-guided treatment strategies have not been explicitly tested

178. Serum Free Light Chain Analysis for the Diagnosis, Management, and Prognosis of Plasma Cell Dyscrasias: Future Research Needs (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/plasma-cell-dyscrasias-sflc-assay-future_research.pdf
     September 01, 2012 - Serum Free Light Chain Analysis for the Diagnosis, Management, and Prognosis of Plasma Cell Dyscrasias: Future Research Needs Future Research Needs Paper Number 23 Serum Free Light Chain Analysis for the Diagnosis, Management, and Prognosis of Plasma Cell Dyscrasias: Future Research Needs Future Research Nee…

179. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/c-diff-infections_executive.pdf
     December 01, 2011 - heterogeneity between studies by examining the differences in sensitivity and specificity in stool samples tested … relevant reference test, (2) use explicit clinical criteria to select patients and stool specimens to be tested

180. Quantitative Synthesis: Chapter 4. Quantifying, Testing, and Exploring Statistical Heterogeneity (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/ehc-presentation-quantitative-synthesis-chapter-4.pdf
     July 01, 2019 - Quantitative Synthesis: Chapter 4. Quantifying, Testing, and Exploring Statistical Heterogeneity Quantitative Synthesis Chapter 4. Quantifying, Testing, and Exploring Statistical Heterogeneity Prepared for: The Agency for Healthcare Research and Quality (AHRQ) Training Modules for Systematic Reviews Methods Guid…